Skip to main content

Peer Review reports

From: Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

Original Submission
10 Aug 2020 Submitted Original manuscript
25 Oct 2020 Author responded Author comments - Dena Firouzabadi
29 Sep 2020 Reviewed Reviewer Report
2 Oct 2020 Reviewed Reviewer Report
Resubmission - Version 2
25 Oct 2020 Submitted Manuscript version 2
13 Nov 2020 Author responded Author comments - Dena Firouzabadi
Resubmission - Version 3
13 Nov 2020 Submitted Manuscript version 3
Publishing
17 Nov 2020 Editorially accepted
11 Jan 2021 Article published 10.1186/s12885-020-07652-0

You can find further information about peer review here.

Back to article page
\